Jam

Kroger, a leading U.S. grocery retailer, received Mental Health America’s 2025 Gold Bell Seal for its workplace mental health initiatives, a distinction awarded to only 40% of applicants. The company earned a perfect holistic wellness score through programs like subsidized counseling, stress management resources, flexible scheduling, and leadership training. As 76% of U.S. workers report moderate-to-high stress levels, Kroger’s focus on psychological safety addresses burnout and retention challenges. MHA’s rigorous audit recognized Kroger’s emphasis on crisis response, inclusion, and team-building. Analysts note this proactive approach strengthens competitiveness in the high-turnover retail sector, aligning employee well-being with business success.

Perimeter Medical Imaging AI partners with Intermountain Health to reduce cancer reoperation rates using advanced OCT imaging and AI. The collaboration, via a Development Support Agreement, will first analyze breast-conserving surgery outcomes to validate the clinical and economic impact of Perimeter’s FDA-cleared S-Series OCT and upcoming AI-driven B-Series device. Intermountain’s integrated healthcare-insurance model enables comprehensive assessment of reoperation costs and patient outcomes. CEO Adrian Mendes noted the data will inform FDA strategies and expansion into new surgical areas. A 2023 study estimated $1.2B annual U.S. costs for repeat breast cancer surgeries, which Perimeter’s real-time margin assessment aims to reduce.

NIO Inc. will convene its 2025 Annual General Meeting in Shanghai on June 25, allowing shareholders registered by May 23 to vote on strategic governance and growth initiatives. Key agenda items include proposals to advance next-gen autonomous driving technology and European market expansion, aligned with board-endorsed goals. The company also disclosed its 2024 Form 20-F, emphasizing R&D progress and battery-swapping infrastructure amid rising competition. Multi-listed shareholders (NYSE, HKEX, SGX) may participate through specified depositaries. The AGM underscores NIO’s focus on investor alignment and operational resilience as it navigates evolving EV industry challenges.

BioNxt Solutions has secured a pivotal European patent for its sublingual drug delivery platform, enhancing its intellectual property position for treating autoimmune diseases. The technology underpins BNT23001, a fast-dissolving oral film of Cladribine aimed at revolutionizing multiple sclerosis therapy by replacing injections with a needle-free, bioavailable alternative. Global patent filings are advancing in the U.S., Japan, and Eurasia, targeting a $150B+ autoimmune market. Upcoming bioequivalence studies in 2025 could enable accelerated EU approval. The platform also shows potential for lupus and arthritis treatments, with preclinical data suggesting improved delivery of biologic agents, positioning BioNxt as a leader in precision drug reformulation.

Endeavour Mining’s May 22, 2025 AGM saw strong shareholder engagement, with 72.79% of issued shares represented. All directors were re-elected with approval rates exceeding 94%, demonstrating investor trust. Key resolutions passed include the Directors’ Remuneration Policy (81.67%) and near-unanimous support for compensation reports (98.53%). Shareholders overwhelmingly authorized capital management actions, including share allotment and buybacks (99.98% approval), reflecting confidence in financial strategy. With 242.2 million shares issued and 103,147 in treasury, the company maintains disciplined capital flexibility. Analysts view the outcomes as reinforcing governance rigor amid gold market uncertainties, positioning Endeavour to advance strategic initiatives.

Guardian Pharmacy Services (NYSE: GRDN) priced its public offering of 7.5 million Class A shares at $21.00 each, including 6.06 million shares from existing stockholders and 1.44 million new shares. Proceeds from new shares will repurchase 1.44 million converted Class B shares, preventing net dilution. Raymond James leads underwriting with a 30-day option for 1.13 million additional shares. The SEC-approved offering, effective May 22, supports Guardian’s strategy to balance capital allocation while serving long-term care facilities in 38 states.

IMPACT Silver (TSXV: IPT) raised C$3.93 million via a dual-tranche private placement, combining C$1.66 million from a LIFE offering (C$0.20/unit) and C$2.27 million from standard units (C$0.18/unit), with tiered warrants exercisable at C$0.24–0.26. Proceeds will accelerate exploration at Mexico’s Plomosas zinc-lead-silver project and revive the Zacualpan silver district, alongside operational upgrades. The financing introduces 15% dilution (20.9M shares), potentially reaching 31.7% if warrants fully convert. While immediate liquidity from LIFE shares benefits investors, challenges include declining Zacualpan silver grades and discontinuous mineralization at Plomosas requiring new discoveries to offset risks.

Journey Energy Inc. (JOY/JRNGF) strengthened its governance at its 2025 AGM, with shareholders approving all resolutions by wide margins. Key outcomes included maintaining a six-member board (85.67% support), director reappointments (79.42%-83.01% approval), KPMG’s auditor retention (97.37%), and adoption of governance modernization measures (82.10%). The re-elected board will prioritize operational continuity, balancing conventional energy production with emissions reduction initiatives. Analysts highlight high approval ratings as a competitive advantage, noting alignment with strategic goals like drilling efficiency and renewable partnerships outlined in the 2025 roadmap.

Silvercorp Metals reported robust fiscal 2025 results with annual revenue up 39% to $298.9 million and adjusted net income of $75.1 million. Q4 revenue surged 76% YoY to $75.1 million, though a $20.6 million derivative charge led to a $7.6 million net loss. The company achieved record-low cash costs ($2.49/oz silver net of byproducts) and doubled cash reserves to $369 million. Key developments include the $181 million Adventus Mining acquisition and $138.6 million operating cash flow funding growth projects. Despite base metals volatility, Silvercorp maintained its dividend streak and strengthened its position in precious/base metals markets.

Hims & Hers Health introduced a six-month Wegovy® subscription at $549/month, a 15% discount on average retail prices, to expand access to prescription weight-loss care. The limited-time offer via telehealth includes consultations, nutritional tools, and progress tracking, leveraging Novo Nordisk’s expanded production. CEO Andrew Dudum emphasized affordability in chronic care, while analysts note the model bridges payer-patient cost gaps. The initiative aligns with a 212% annual rise in metabolic health consultations, reflecting consumer demand for preventive solutions. Promotion runs through June 30, 2025, with eligibility criteria on the company’s platform. Hims & Hers continues offering compounded alternatives and behavioral programs in the $100 billion wellness sector.